Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

However if you have a medical condition that affects your driving but don't voluntarily give up your licence, you must inform the DVLA, which will decide if you can continue holding a driving licence.

Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on LRMR stock, giving a Buy rating on January 24.Invest with ...

The data analysis is being finalized, and we remain on track to report topline results in early February ... Parkinson’s disease, and Friedreich’s Ataxia. New, non-clinical data was presented that ...

In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Larimar Therapeutics (LRMR – Research Report), ...

According to GlobalData, Phase II drugs for Spinocerebellar Ataxia (SCA) have a 29% phase transition success rate (PTSR) indication benchmark for progressing into Phase III. GlobalData’s report ...

Lions postgame injury report after season-ending loss to Commanders, with updates on Amik Robertson, Penei Sewell and more ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Suzanne is a content marketer, writer ...

Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Friedreich Ataxia - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides ...

Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Friedreich Ataxia - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides top ...